They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Size: px
Start display at page:

Download "They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:"

Transcription

1 overview bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: NICE Pathway last updated: 30 August 2017 This document contains a single flowchart and uses numbering to link the boxes to the associated recommendations. Page 1 of 10

2 overview Page 2 of 10

3 overview 1 Improving people's diet No additional information 2 Strategy, policy and commissioning See / Strategy, policy and commissioning for diet 3 Training See / Training on diet 4 Areas of work (settings) No additional information 5 Lifestyle advice on diet and physical activity See / Lifestyle advice on diet and physical activity 6 Primary care and community health services See / Recommendations about diet for primary care and community health services 7 Community programmes including leisure and weight management See / Community and leisure services and weight management programmes Page 3 of 10

4 overview 8 Commercial organisations, including manufacturing, retailing, catering and weight management Manufacturers of products for women Folic acid Manufacturers should include information with their products on the importance of folic acid supplements before and during pregnancy. Relevant products may include pregnancy tests, sanitary products, contraceptives and ovulation predictor kits. Vitamin D For advice for manufacturers on vitamin D supplements, see NICE's recommendations on vitamin D: supplement use in specific population groups. Take-aways and other food outlets See recommendations on standards for take-aways and other food outlets. Providers of weight management programmes See recommendations on weight management programmes. 9 Schools, early years education and childcare See / in schools, early years education and childcare 10 Workplaces, including the NHS and local authorities Overarching recommendation All workplaces, particularly large organisations such as the NHS and local authorities, should address the prevention and management of obesity, because of the considerable impact on the health of the workforce and associated costs to industry. Workplaces are encouraged to collaborate with local partnerships and to ensure that action is in line with the local obesity strategy (in England). Page 4 of 10

5 overview For all workplaces Workplaces should provide opportunities for staff to eat a healthy diet and be more physically active, through: active and continuous promotion of healthy choices in restaurants, hospitality, vending machines and shops for staff and clients, in line with existing Food Standards Agency guidance working practices and policies, such as active travel policies for staff and visitors. Incentive schemes (such as policies on travel expenses, the price of food and drinks sold in the workplace and contributions to gym membership) that are used in a workplace should be sustained and part of a wider programme to support staff in managing weight, improving diet and increasing activity levels. For NHS, public organisations and large commercial organisations Workplaces providing health checks for staff should ensure that they address weight, diet and activity, and provide ongoing support. Action to improve food and drink provision in the workplace, including restaurants, hospitality and vending machines, should be supported by tailored educational and promotional programmes, such as a behavioural intervention or environmental changes (for example, food labelling or changes to availability). For this to be effective, commitment from senior management, enthusiastic catering management, a strong occupational health lead, links to other on-site health initiatives, supportive pricing policies and heavy promotion and advertisement at point of purchase are likely to be needed. See also recommendations on public sector catering, and recommendations for workplaces in NICE's recommendations on physical activity. Align actions to improve diet with strategies to prevent obesity at a community level to ensure a coherent, integrated approach (see what NICE says on obesity: working with local communities). Page 5 of 10

6 overview Support for workplaces from health professionals Support for workplaces Health professionals such as occupational health staff and public health practitioners should establish partnerships with local businesses and support the implementation of workplace programmes to prevent and manage obesity. Quality standards The following quality statements are relevant to this part of the interactive flowchart. Obesity in adults: prevention and lifestyle weight management programmes quality standard 2. Nutritional information at the point of choosing food and drink options Obesity in children and young people: prevention and lifestyle weight management programmes quality standard 2. Nutritional information at the point of choosing food and drink options obesity prevention and lifestyle weight management in children and young people Page 6 of 10

7 overview Reference nutrient intake is the amount of a nutrient needed to meet the needs of 97.5% of individuals in a group. Reference nutrient intake for a given nutrient may vary by gender, age and physiological status (for example during pregnancy and lactation). The reference nutrient intake is not a minimum target that all people need to achieve, but the risk of deficiency is minimised if the average population intake exceeds it. The current reference nutrient intakes (µg/day) for vitamin D are: 10 micrograms of vitamin D per day, throughout the year, for everyone in the general population aged 4 years and older 10 micrograms of vitamin D per day for pregnant and lactating women and population groups at increased risk of vitamin D deficiency. Although the entire population of the UK are at risk of having a low vitamin D status, evidence was only considered in regard to increasing the supplement use for these specific population groups: All pregnant and breastfeeding women, particularly teenagers and young women. Infants and children under 4 years (breast fed, non-breast fed and mixed fed). People over 65. People who have low or no exposure to the sun. For example, those who cover their skin for cultural reasons, who are housebound or confined indoors for long periods. People who have darker skin, for example, people of African, African Caribbean and South Asian origin. All population groups are currently advised to take a supplement that meets 100% of the reference nutrient intake for their age group. All infants and young children aged 6 months to 3 years are advised to take a daily supplement containing vitamin D in the form of vitamin drops. But infants who are fed infant formula will not need them until they have less than 500 ml of infant formula a day, because these products are fortified with vitamin D. Breastfed infants may need drops containing vitamin D from 1 month of age if their mother has not taken vitamin D supplements throughout pregnancy. ('Vitamin D advice for supplements for at risk groups letter from the UK Chief Medical Officers' Department of Health). BMI body mass index Page 7 of 10

8 overview CVD cardiovascular disease IPTFAs industrially-produced trans fatty acids Sources Obesity prevention (2006 updated 2015) NICE guideline CG43 Maternal and child nutrition (2008) NICE guideline PH11 Your responsibility Guidelines The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian. Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Page 8 of 10

9 overview Technology appraisals The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Medical technologies guidance, diagnostics guidance and interventional procedures guidance The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties. Page 9 of 10

10 overview Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Page 10 of 10

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Strategy,, policy and commissioning to delay or prevent ent of dementia, bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Ongoing care for adults with psychosis or schizophrenia bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Gestational diabetes: risk assessment, testing, diagnosis and management bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Recognising and managing bipolar disorder in adults in primary care bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Strategy,, policy and commissioning on hepatitis B and C testing NICE Pathways bring together everything NICE says on a topic in an interactive flowchart. NICE Pathways are interactive and designed to

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Chronic fatigue syndrome myalgic encephalomyelitis elitis overview bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Cryopreservation to preserve e fertility in people diagnosed with cancer bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: : treatment bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Step 3: GAD with marked functional impairment or that has not improved after step 2 interventionsentions bring together everything NICE says on a topic in an interactive flowchart. are interactive and

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Managing comorbid health problems in people with eating disorders bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: : assessing the risk of fragility fracture bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: in children and young people: recognition, detection, risk profiling and NICE Pathways bring together everything NICE says on a topic in an interactive flowchart. NICE Pathways are interactive and designed

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Coexisting mental disorders in adults with autism spectrum disorder bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are

More information

Choosing and delivering ering interventions entions for

Choosing and delivering ering interventions entions for Choosing and delivering ering interventions entions for psychosis and schizophrenia in adults bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

14. HEALTHY EATING INTRODUCTION

14. HEALTHY EATING INTRODUCTION 14. HEALTHY EATING INTRODUCTION A well-balanced diet is important for good health and involves consuming a wide range of foods, including fruit and vegetables, starchy whole grains, dairy products and

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: diagnosis and assessment bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

Risk assessment for type 2 diabetes

Risk assessment for type 2 diabetes Preventing type 2 diabetes NICE 2019. All rights reserved. Subject to Notice of rights. NICE Pathways NICE Pathways bring together everything NICE says on a topic in an interactive flowchart. NICE Pathways

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Assessment and immediate management of suspected acute coronary syndrome bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Assessment and investigation of urinary incontinence in women bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

Smoking cessation interventions and services

Smoking cessation interventions and services National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These

More information

Workplace Nutrition and Public Health Context. Jade Clark, RD BDA Work Ready Accredited Dietitian

Workplace Nutrition and Public Health Context. Jade Clark, RD BDA Work Ready Accredited Dietitian Workplace Nutrition and Public Health Context Jade Clark, RD BDA Work Ready Accredited Dietitian Workplace Health NHS 5 Year Forward View (2014) NICE Guidance: Mental wellbeing at work (PH22) 2009 Physical

More information

NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49

NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49 Non-alcoholic fatty liver disease (NAFLD): assessment and management NICE guideline Published: 6 July 20 nice.org.uk/guidance/ng49 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg143

Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg143 Sickle cell disease: managing acute painful episodes in hospital Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg143 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

HS58A. Healthy Start vitamins and why you need them

HS58A. Healthy Start vitamins and why you need them HS58A Healthy Start vitamins and why you need them Folic acid Taking a folic acid supplement before you re pregnant and until the 12th week of your pregnancy is really important because it reduces the

More information

Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children

Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children NICE guideline FIrst draft for consultation, March 2006 If you wish to comment on this

More information

Islington JSNA 2010/11 Healthy Eating

Islington JSNA 2010/11 Healthy Eating Islington JSNA 2010/11 Healthy Eating INTRODUCTION A well-balanced diet is important for good health and involves consuming a wide range of foods, including fruit and vegetables, starchy whole grains,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National

More information

Kent Joint Commissioning Action Plan For Adults with Autism and or ADHD (2017 / 2021)

Kent Joint Commissioning Action Plan For Adults with Autism and or ADHD (2017 / 2021) Easy Read Kent Joint Commissioning Action Plan For Adults with Autism and or ADHD (2017 / 2021) Action Plan The plan was developed to address the needs identified from the Kent Autism Strategy and Joint

More information

NICE offer to STPs: CVD prevention

NICE offer to STPs: CVD prevention NICE offer to STPs: CVD prevention Zoe Girdis Regional Technical Adviser South of England and Channel Islands NICE support for STPs Based on the best available evidence of what works and is costeffective,

More information

Guideline scope Smoking cessation interventions and services

Guideline scope Smoking cessation interventions and services 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Topic NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Smoking cessation interventions and services This guideline

More information

Alcohol interventions in secondary and further education

Alcohol interventions in secondary and further education National Institute for Health and Care Excellence Guideline version (Draft for Consultation) Alcohol interventions in secondary and further education NICE guideline: methods NICE guideline Methods

More information

Clinical guideline Published: 17 March 2008 nice.org.uk/guidance/cg64

Clinical guideline Published: 17 March 2008 nice.org.uk/guidance/cg64 Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective e endocarditis in adults and children undergoing interventionalentional procedures Clinical guideline Published:

More information

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:

More information

Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516

Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516 Cabozantinib for treating medullary thyroid cancer Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

NACPH ( National Association for Consumer Protection in Hungary) response to the European Commission s Green Paper on

NACPH ( National Association for Consumer Protection in Hungary) response to the European Commission s Green Paper on István Garai Executive president Livia Dömölki Food advisor Országos Fogyasztóvédelmi Egyesület (National Association for Consumer Protection in Hungary) Budapest Logodi u. 22-24. H-1012 phon: 36 1 3111830

More information

Smoking cessation services

Smoking cessation services Issue date: February 2008 Quick reference guide Smoking cessation services This quick reference guide presents the recommendations made in Smoking cessation services in primary care, pharmacies, local

More information

NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56

NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56 Multimorbidity: clinical assessment and management NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499 Glecaprevir pibrentasvir for treating chronic hepatitis C Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499 NICE 2018. All rights reserved. Subject to Notice of rights

More information

Uterine artery embolisation for treating adenomyosis

Uterine artery embolisation for treating adenomyosis Uterine artery embolisation for treating Issued: December 2013 guidance.nice.org.uk/ipg NICE has accredited the process used by the NICE Interventional Procedures Programme to produce interventional procedures

More information

Public health guideline Published: 26 March 2014 nice.org.uk/guidance/ph51

Public health guideline Published: 26 March 2014 nice.org.uk/guidance/ph51 Contraceptive e services for under 25s Public health guideline Published: 26 March 2014 nice.org.uk/guidance/ph51 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

NICE guideline Published: 2 September 2015 nice.org.uk/guidance/ng20

NICE guideline Published: 2 September 2015 nice.org.uk/guidance/ng20 Coeliac disease: recognition, assessment and management NICE guideline Published: 2 September 2015 nice.org.uk/guidance/ng20 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

What needs to happen in England

What needs to happen in England What needs to happen in England We ve heard from over 9,000 people across the UK about what it is like to live with diabetes and their hopes and fears for the future. Over 6,000 of them live in England;

More information

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta500

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta500 Ceritinib for untreated ALK-positive non- small-cell lung cancer Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta500 NICE 2018. All rights reserved. Subject to Notice of

More information

Technology appraisal guidance Published: 6 September 2017 nice.org.uk/guidance/ta476

Technology appraisal guidance Published: 6 September 2017 nice.org.uk/guidance/ta476 Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer Technology appraisal guidance Published: 6 September 2017 nice.org.uk/guidance/ta476 NICE 2018. All

More information

Creating a Smoke Free Workplace Policy

Creating a Smoke Free Workplace Policy Creating a Smoke Free Workplace Policy Solent NHS Trust policies can only be considered to be valid and up-to-date if viewed on the intranet. Please visit the intranet for the latest version. Purpose of

More information

Vitamin D Deficiency

Vitamin D Deficiency PATIENT INFORMATION LEAFLET Vitamin D Deficiency What is vitamin D? Vitamin D is essential for good health, strong bones and muscles. Unlike other vitamins, we do not need to get vitamin D from food. Our

More information

Technology appraisal guidance Published: 27 March 2019 nice.org.uk/guidance/ta572

Technology appraisal guidance Published: 27 March 2019 nice.org.uk/guidance/ta572 Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes Technology appraisal guidance Published: 27 March 2019 nice.org.uk/guidance/ta572 NICE 2019. All rights reserved. Subject to

More information

Dear Ms Smith, Linda Smith Assistant Clerk to the Public Health Petitions Committee TG.01 EDINBURGH EH99 1SP

Dear Ms Smith, Linda Smith Assistant Clerk to the Public Health Petitions Committee TG.01 EDINBURGH EH99 1SP Linda Smith Assistant Clerk to the Public Health Petitions Committee TG.01 EDINBURGH EH99 1SP 7 th September 2009 Our reference: FSA OR 897 Dear Ms Smith, RE: Consideration of Petition PE1259 Thank you

More information

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126 Stable angina: management Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Communications and Engagement Approach

Communications and Engagement Approach Communications and Engagement Approach 2016-2020 NHS Cumbria CCG commissioning hospital and community services to get the best healthcare and health outcomes for our communities Contents Section 1 Section

More information

Extracorporeal shockwave therapy for refractory Achilles tendinopathy

Extracorporeal shockwave therapy for refractory Achilles tendinopathy Extracorporeal shockwave therapy for refractory Achilles Issued: August 2009 www.nice.org.uk/ipg312 NHS Evidence has accredited the process used by the NICE Interventional Procedures Programme to produce

More information

Healthy Weight: Healthy Wales. Youth and community version

Healthy Weight: Healthy Wales. Youth and community version Healthy Weight: Healthy Wales Youth and community version Introduction The Welsh Government want everyone in Wales to be a healthy weight. We want people to eat healthy food and be active. We all make

More information

HEALTHY WEIGHT AND THE WORKPLACE. a guide for employers

HEALTHY WEIGHT AND THE WORKPLACE. a guide for employers HEALTHY WEIGHT AND THE WORKPLACE a guide for employers This Topic Guide has been commissioned and reviewed by Public Health England (PHE), but developed by Health@Work. The purpose is to provide information

More information

Vitamin D the role for HCPs

Vitamin D the role for HCPs Vitamin D the role for HCPs Judy More Paediatric Dietitian and Registered Nutritionist Colief Expert Panel In association with Vitamin D The role for HCPs 2 3 4 What is vitamin D? The two forms Why are

More information

Technology appraisal guidance Published: 26 April 2017 nice.org.uk/guidance/ta442

Technology appraisal guidance Published: 26 April 2017 nice.org.uk/guidance/ta442 Ixekizumab for treating moderate to severe ere plaque psoriasis Technology appraisal guidance Published: 26 April 2017 nice.org.uk/guidance/ta442 NICE 2017. All rights reserved. Subject to Notice of rights

More information

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471 Eluxadoline for treating irritable bowel syndrome with diarrhoea Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471 NICE 2017. All rights reserved. Subject to Notice of

More information

Technology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547

Technology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547 Tofacitinib for moderately to severelyerely active ulcerative colitis Technology appraisal guidance Published: 28 November 2018 nice.org.uk/guidance/ta547 NICE 2019. All rights reserved. Subject to Notice

More information

Technology appraisal guidance Published: 20 December 2017 nice.org.uk/guidance/ta496

Technology appraisal guidance Published: 20 December 2017 nice.org.uk/guidance/ta496 Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor- positive, HER2-negative, e, locally advanced or metastatic breast cancer Technology appraisal guidance Published: 20 December

More information

Technology appraisal guidance Published: 24 August 2016 nice.org.uk/guidance/ta405

Technology appraisal guidance Published: 24 August 2016 nice.org.uk/guidance/ta405 Trifluridine tipirracil for previously treated metastatic colorectal cancer Technology appraisal guidance Published: 24 August 2016 nice.org.uk/guidance/ta405 NICE 2018. All rights reserved. Subject to

More information

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 Ovarian cancer: recognition and initial management Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy ( )

Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy ( ) Executive Summary: Toi Te Ora s Childhood Obesity Prevention Strategy (2013 2023) This briefing paper has been developed by Toi Te Ora Public Health Service (Toi Te Ora) to provide an evidence-based strategic

More information

Dianne Johnson / Lee Panter / Sarah McNulty

Dianne Johnson / Lee Panter / Sarah McNulty Cardiovascular Disease (heart disease and stroke) READER INFORMATION Need Identified Lead Author Cardiovascular Disease Dianne Johnson / Lee Panter / Sarah McNulty Date completed 07/02/11 Director approved

More information

Technology appraisal guidance Published: 16 May 2018 nice.org.uk/guidance/ta520

Technology appraisal guidance Published: 16 May 2018 nice.org.uk/guidance/ta520 Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy Technology appraisal guidance Published: 16 May 2018 nice.org.uk/guidance/ta520 NICE 2018. All rights

More information

Case scenarios: Patient Group Directions

Case scenarios: Patient Group Directions Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios

More information

LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group. Terms of Reference

LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group. Terms of Reference LOCAL EQUALITY ADVISORY FORUM (LEAF) A Staffordshire CCGs Equality & Inclusion Group Terms of Reference (1) Introduction and Purpose Promoting equality and inclusion is at the heart of our values. We will

More information

Nutrition and Dietetic Health Improvement Team

Nutrition and Dietetic Health Improvement Team Nutrition and Dietetic Health Improvement Team Annual Report 2017-2018 We strive to improve the health and wellbeing of individuals and communities throughout Forth Valley by leading on the nutrition agenda,

More information

CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP

CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP 1. AIMS To unify and co-ordinate services for children, young people and families in line with the Children Act 2004 To oversee the

More information

Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164

Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164 Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer Clinical guideline Published: 25 June 2013 nice.org.uk/guidance/cg164

More information

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464 Bisphosphonates for treating osteoporosis Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Simply, participation means individual s involvement in decisions that affect them.

Simply, participation means individual s involvement in decisions that affect them. Simply, participation means individual s involvement in decisions that affect them. NHS England guidance on participation sets out two types of participation in healthcare: 1) people s involvement in decisions

More information

Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg118

Clinical guideline Published: 23 March 2011 nice.org.uk/guidance/cg118 Colorectal cancer prevention: ention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas Clinical guideline Published: March 2011 nice.org.uk/guidance/cg118 NICE 2018.

More information

Health Promotion and Healthy Start

Health Promotion and Healthy Start Health Promotion and Healthy Start 6 contractual Public Health campaigns: Month Campaign April/May Healthy Start and Folic Acid (NHS Norfolk campaign - Sexual health (tie in with 'Just Ask' refresh)) June/July

More information

2017 Health and Food Technology. Advanced Higher. Finalised Marking Instructions

2017 Health and Food Technology. Advanced Higher. Finalised Marking Instructions National Qualifications 2017 2017 Health and Food Technology Advanced Higher Finalised Marking Instructions Scottish Qualifications Authority 2017 The information in this publication may be reproduced

More information

Community alcohol detoxification in primary care

Community alcohol detoxification in primary care Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their

More information

The National perspective Public Health England s vision, mission and priorities

The National perspective Public Health England s vision, mission and priorities The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England

More information

NO SMOKING POLICY. Organisational

NO SMOKING POLICY. Organisational NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index

More information

SFHAI1 Use recognised theoretical models to provide therapeutic support to individuals who misuse substances

SFHAI1 Use recognised theoretical models to provide therapeutic support to individuals who misuse substances Use recognised theoretical models to provide therapeutic support to individuals who misuse substances Overview For this standard you need to provide therapeutic support to individuals who misuse substances.

More information

The new PH landscape Opportunities for collaboration

The new PH landscape Opportunities for collaboration The new PH landscape Opportunities for collaboration Dr Ann Hoskins Director Children, Young People & Families Health and Wellbeing Content Overview of new PH system PHE function and structure Challenges

More information

Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127

Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127 Hypertension in adults: diagnosis and management Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Technology appraisal guidance Published: 12 July 2017 nice.org.uk/guidance/ta456

Technology appraisal guidance Published: 12 July 2017 nice.org.uk/guidance/ta456 Ustekinumab for moderately to severelyerely active Crohn s disease after previous treatment Technology appraisal guidance Published: 12 July 2017 nice.org.uk/guidance/ta456 NICE 2017. All rights reserved.

More information

Technology appraisal guidance Published: 21 November 2018 nice.org.uk/guidance/ta546

Technology appraisal guidance Published: 21 November 2018 nice.org.uk/guidance/ta546 Padeliporfin for untreated localised prostate cancer Technology appraisal guidance Published: 21 November 2018 nice.org.uk/guidance/ta546 NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

PUBLIC HEALTH GUIDANCE SCOPE

PUBLIC HEALTH GUIDANCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guidance title PUBLIC HEALTH GUIDANCE SCOPE Oral health: local authority strategies to improve oral health particularly among vulnerable groups 1.1 Short

More information

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531

Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531 Pembrolizumab for untreated PD- L1-positive metastatic non-small-cell lung cancer Technology appraisal guidance Published: 18 July 2018 nice.org.uk/guidance/ta531 NICE 2018. All rights reserved. Subject

More information